Brief: Pharmacyte Biotech Acquires $5 Million Stake In Emerging Women’S Health Innovator Femasys
15/11/2023 15:02
Nov 15 (Reuters) - Femasys Inc FEMY.O :
* PHARMACYTE BIOTECH ACQUIRES $5 MILLION STAKE IN EMERGING
WOMEN’S
HEALTH INNOVATOR FEMASYS, INC.
* PHARMACYTE BIOTECH INC - PHARMACYTE'S INTERIM CEO JOSH
SILVERMAN
WILL JOIN FEMASYS' BOARD OF DIRECTORS
Source text for Eikon: ID:nBw3Pr8n6a
Further company coverage: FEMY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Femasys
See all newsBrief: Femasys - Files For Resale Of Up To 28,124,997 Shares Of Common Stock - SEC Filing
Brief: Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc
Femasys Inc reports results for the quarter ended June 30 - Earnings Summary
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview